跳至主要内容
临床试验/JPRN-jRCT2080221272
JPRN-jRCT2080221272未知3 期

A phase III parallel-group comparison study of HOB-294 in patients with overactive bladder.

Hisamitsu Pharmaceutical Co., Inc.0 个研究点开始时间: 2010年10月19日最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • Patients with symptoms of overactive bladder for at least 24 weeks before obtaining informed consent

排除标准

  • - Patients with genuine stress incontinence
  • - Patients with micturition difficulty, retention of urine, or other symptoms due to lower urinary tract obstruction
  • - Patients for whom it is difficult to walk to the lavatory without assistance, patients who cannot measure the urine volume by themselves, and patients who cannot keep a bladder log by themselves

研究者

相似试验